Cargando…

Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma

Although cytoplasmic AMP-activated protein kinase (AMPK) has been known as a tumor-suppressor protein, nuclear AMPK is suggested to support clear cell renal cell carcinoma (ccRCC). In addition, pAMPK interacts with TGF-β/SMAD, which is one of the frequently altered pathways in ccRCC. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Minsun, Lee, Jeong Hoon, Lee, Cheol, Park, Jeong Hwan, Park, Yu Rang, Moon, Kyung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826619/
https://www.ncbi.nlm.nih.gov/pubmed/31640193
http://dx.doi.org/10.3390/cancers11101602
_version_ 1783465131868422144
author Jung, Minsun
Lee, Jeong Hoon
Lee, Cheol
Park, Jeong Hwan
Park, Yu Rang
Moon, Kyung Chul
author_facet Jung, Minsun
Lee, Jeong Hoon
Lee, Cheol
Park, Jeong Hwan
Park, Yu Rang
Moon, Kyung Chul
author_sort Jung, Minsun
collection PubMed
description Although cytoplasmic AMP-activated protein kinase (AMPK) has been known as a tumor-suppressor protein, nuclear AMPK is suggested to support clear cell renal cell carcinoma (ccRCC). In addition, pAMPK interacts with TGF-β/SMAD, which is one of the frequently altered pathways in ccRCC. In this study, we investigated the prognostic significance of pAMPK with respect to subcellular location and investigated its interaction with TGF-β/SMAD in ccRCC. Immunohistochemical staining for pAMPK, pSMAD2 and SMAD4 was conducted on tissue microarray of 987 ccRCC specimens. Moreover, the levels of pSMAD2 were measured in Caki-1 cells treated with 5-aminoimidazole-4-carboxamide ribonucleotide. The relationship between AMPK/pAMPK and TGFB1 expression was determined using the TCGA database. As a result, pAMPK positivity, either in the cytoplasm or nuclei, was independently associated with improved ccRCC prognosis, after adjusting for TNM stage and WHO grade. Furthermore, pAMPK-positive ccRCC displayed increased pSMAD2 and SMAD4 expression, while activation of pAMPK increased pSMAD2 in Caki-1 cells. However, AMPK/pAMPK expression was inversely correlated with TGFB1 expression in the TCGA database. Therefore, pAMPK immunostaining, both in the cytoplasm and nuclei, is a useful prognostic biomarker for ccRCC. pAMPK targets TGF-β-independent phosphorylation of SMAD2 and activates pSMAD2/SMAD4, representing a novel anti-tumoral mechanism of pAMPK in ccRCC.
format Online
Article
Text
id pubmed-6826619
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68266192019-11-18 Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma Jung, Minsun Lee, Jeong Hoon Lee, Cheol Park, Jeong Hwan Park, Yu Rang Moon, Kyung Chul Cancers (Basel) Article Although cytoplasmic AMP-activated protein kinase (AMPK) has been known as a tumor-suppressor protein, nuclear AMPK is suggested to support clear cell renal cell carcinoma (ccRCC). In addition, pAMPK interacts with TGF-β/SMAD, which is one of the frequently altered pathways in ccRCC. In this study, we investigated the prognostic significance of pAMPK with respect to subcellular location and investigated its interaction with TGF-β/SMAD in ccRCC. Immunohistochemical staining for pAMPK, pSMAD2 and SMAD4 was conducted on tissue microarray of 987 ccRCC specimens. Moreover, the levels of pSMAD2 were measured in Caki-1 cells treated with 5-aminoimidazole-4-carboxamide ribonucleotide. The relationship between AMPK/pAMPK and TGFB1 expression was determined using the TCGA database. As a result, pAMPK positivity, either in the cytoplasm or nuclei, was independently associated with improved ccRCC prognosis, after adjusting for TNM stage and WHO grade. Furthermore, pAMPK-positive ccRCC displayed increased pSMAD2 and SMAD4 expression, while activation of pAMPK increased pSMAD2 in Caki-1 cells. However, AMPK/pAMPK expression was inversely correlated with TGFB1 expression in the TCGA database. Therefore, pAMPK immunostaining, both in the cytoplasm and nuclei, is a useful prognostic biomarker for ccRCC. pAMPK targets TGF-β-independent phosphorylation of SMAD2 and activates pSMAD2/SMAD4, representing a novel anti-tumoral mechanism of pAMPK in ccRCC. MDPI 2019-10-21 /pmc/articles/PMC6826619/ /pubmed/31640193 http://dx.doi.org/10.3390/cancers11101602 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jung, Minsun
Lee, Jeong Hoon
Lee, Cheol
Park, Jeong Hwan
Park, Yu Rang
Moon, Kyung Chul
Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma
title Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma
title_full Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma
title_fullStr Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma
title_full_unstemmed Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma
title_short Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma
title_sort prognostic implication of pampk immunohistochemical staining by subcellular location and its association with smad protein expression in clear cell renal cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826619/
https://www.ncbi.nlm.nih.gov/pubmed/31640193
http://dx.doi.org/10.3390/cancers11101602
work_keys_str_mv AT jungminsun prognosticimplicationofpampkimmunohistochemicalstainingbysubcellularlocationanditsassociationwithsmadproteinexpressioninclearcellrenalcellcarcinoma
AT leejeonghoon prognosticimplicationofpampkimmunohistochemicalstainingbysubcellularlocationanditsassociationwithsmadproteinexpressioninclearcellrenalcellcarcinoma
AT leecheol prognosticimplicationofpampkimmunohistochemicalstainingbysubcellularlocationanditsassociationwithsmadproteinexpressioninclearcellrenalcellcarcinoma
AT parkjeonghwan prognosticimplicationofpampkimmunohistochemicalstainingbysubcellularlocationanditsassociationwithsmadproteinexpressioninclearcellrenalcellcarcinoma
AT parkyurang prognosticimplicationofpampkimmunohistochemicalstainingbysubcellularlocationanditsassociationwithsmadproteinexpressioninclearcellrenalcellcarcinoma
AT moonkyungchul prognosticimplicationofpampkimmunohistochemicalstainingbysubcellularlocationanditsassociationwithsmadproteinexpressioninclearcellrenalcellcarcinoma